Global markets | Why we need to think global to tackle AMR
Moderator:
- Marc Lemonnier – Founding CEO, Antabio SAS
Speakers:
- Heiman Wertheim – Head of Clinical Microbiology Department, Radboud University Medical Center
This content has been restricted to logged in users only. Please login to view this content.
- Anand Anandkumar – CEO, Bugworks
- Alexandra Cameron – Senior Technical Manager Strategy Team, UNITAID
- Bruce Altevogt, Vice President and Head External Medical Engagement, Hospital Business Unit, Pfizer
This content has been restricted to logged in users only. Please login to view this content.
Play Video
This might also be of interest for you:
- More information about the Open access global treatment guideline for antimicrobials, by Heiman Wertheim
- Wellcome Trust and Pfizer launch surveillance program to combat growing threat of antimicrobial resistance in sub-saharan africa
- Unitaid is supporting the LONGEVITY project of University of Liverpool
- Unitaid deepens its commitment to fighting epidemics old and new, marks World Tuberculosis Day
- C-Camp has launched C-CAMP COVID-19 innovations deployment accelerator
- Life science incubator C-CAMP launches AMR accelerator programme to encourage antimicrobial resistance innovations,14 August 2020
